Turkey Tail Mushroom and Cancer Treatment Support
Turkey tail's PSK compound has been approved as a cancer adjunct therapy in Japan since 1977. Here's what the clinical evidence shows and how it's used alongside conventional treatment.
The Short Answer
Turkey tail mushroom's PSK (polysaccharide-K, also called Krestin) has been approved as a cancer adjunct therapy in Japan since 1977 and is covered by Japan's national health insurance. Over 400 clinical trials have studied PSK as an adjunct to chemotherapy and radiation, primarily for gastric, colorectal, and breast cancers. A 2012 NIH-funded trial — the first FDA-approved clinical trial of a mushroom supplement in the US — found turkey tail extract improved immune function in breast cancer patients after conventional treatment.
What "Cancer Adjunct Therapy" Means
Turkey tail is not a cancer treatment — it does not directly kill cancer cells or shrink tumors. It is an adjunct therapy, meaning it is used alongside conventional treatment (chemotherapy, radiation, surgery) to support the immune system's ability to identify and destroy remaining cancer cells.
The mechanism is immunomodulation: PSK activates natural killer (NK) cells and T-lymphocytes — the immune cells responsible for cancer cell surveillance and destruction. Chemotherapy and radiation suppress the immune system, which is why immune support during and after treatment is clinically meaningful.
The Clinical Evidence
Japanese clinical trials: Multiple large RCTs in Japan have found that PSK supplementation alongside chemotherapy improves 5-year survival rates in gastric and colorectal cancer patients. A meta-analysis of 8,009 patients found PSK significantly improved disease-free survival.
2012 NIH-funded trial: Published in ISRN Oncology, this study found that breast cancer patients who received turkey tail extract after conventional treatment showed significantly improved NK cell activity and CD8+ T-cell counts compared to controls. This was the first FDA-approved clinical trial of a mushroom supplement in the United States.
Important Caveats
Turkey tail is not a substitute for conventional cancer treatment. It is a supportive therapy that may enhance the immune response during and after treatment. Always inform your oncologist about any supplements you are taking — timing relative to chemotherapy sessions may affect both the supplement's effectiveness and the chemotherapy's mechanism.
Frequently Asked Questions
Can turkey tail prevent cancer?
There is no clinical evidence that turkey tail prevents cancer in healthy people. Its evidence base is for adjunct use during and after conventional cancer treatment, not for primary prevention.
Is turkey tail safe during chemotherapy?
Turkey tail has been used as a chemotherapy adjunct in Japan for decades with an excellent safety profile. However, always inform your oncologist before starting any supplement during cancer treatment. Some chemotherapy drugs have specific interactions with supplements that your oncologist needs to assess.
How much turkey tail is used in cancer adjunct protocols?
Japanese clinical trials used PSK doses of 3g/day. The NIH-funded US trial used 3–9g/day of turkey tail powder. Quality tinctures concentrate the active compounds, so smaller volumes can deliver equivalent doses.
Where can I get PSK specifically?
PSK (Krestin) is available as a pharmaceutical product in Japan. In the US, turkey tail supplements containing PSK are available as dietary supplements. Look for products that specify fruiting body source and provide beta-glucan content data — these are the most reliable indicators of PSK content.
This article is for informational purposes only and does not constitute medical advice. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before making any changes to your health regimen.